Drug

Tumor necrosis factor-alpha, CNGRC fusion protein, human clinical trials

studies test it: 17
open now: 0
in phase 3: 0
first study started: 2004

How studies write it

Studies that test it under each name

Name

NGR-hTNF: 16

Studies by the year they started

17 studies that test it; most in 2007 (4)

Studies that test tumor necrosis factor-alpha, CNGRC fusion protein, human, by start year
Year	Studies
2004	1
2005	1
2006	3
2007	4
2008	1
2009	2
2010	1
2011	2
2013	1
2016	1

By phase

A phase 1/2 study counts in both.

Phase 1: 5
Phase 2: 12

What it is tested for

Each study’s main condition, where its own words name it.

Neoplasms: 3
Ovarian Neoplasms: 3
Mesothelioma, Malignant: 2
Lymphoma, Large B-Cell, Diffuse: 1
Small Cell Lung Carcinoma: 1
Colorectal Neoplasms: 1
Carcinoma, Non-Small-Cell Lung: 1
Sarcoma: 1
Colonic Neoplasms: 1
Carcinoma, Hepatocellular: 1
Head and Neck Neoplasms: 1

Who runs them

Industry 15 · Other 2

AGC Biologics S.p.A. (15) · Andres J. M. Ferreri (1) · European Organisation for Research and Treatment of Cancer - EORTC (1)

Often tested with

Tested in the same studies.

Doxorubicin (5) · Cyclophosphamide (1) · Vincristine (1) · Prednisone (1) · Oxaliplatin (1) · Cisplatin (1)

Studies

Open first, then newest update. How each study uses tumor necrosis factor-alpha, CNGRC fusion protein, human is read from its arms, and is right about nine times in ten.